The Global "Intra-Dialytic Hypotension Market" is expected to grow at a high CAGR during the forecasting period (2023-2030).
Intra-Dialytic Hypotension (IDH) is defined as a fall in systolic blood pressure by =20 mmHg or in mean arterial pressure (MAP) by 10 mmHg correlated with symptoms, which include nausea, abdominal discomfort, yawning, sighing, vomiting, muscle cramps, restlessness, dizziness or fainting, and anxiety.
etrics |
Details |
Market CAGR |
High |
Segments Covered |
By Product Type ,By Distribution Channel, and By Region |
Report Insights Covered |
Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and acquisitions, New Product Launches, Growth Strategies, Revenue Analysis, and Other key insights. |
Fastest Growing Region |
Asia Pacific |
Largest Market Share |
North America |
Get A Free Sample Click Here
The Intra-Dialytic Hypotension market is growing due to the increasing number of patients suffering from kidney disorders and undergoing dialysis treatment globally. Other drivers for this market are the technological advancements in the medical field. Recent technological trends such as hemodialysis testing devices along with blood pressure monitors are beneficial for patients. Online hematocrit monitoring devices help calculate plasma volume changes, ultrafiltration, and plasma refill rates (UFR, PRR).
Among the global population suffering from kidney failure, 76% of dialysis patients consume anti-hypertensive medications. Intra-dialytic hypotension is observed in 15% of hemodialysis patients.
However, low purchasing power and hospitals' unavailability of necessary facilities are the major restraints in this market.
Based on the type of testing device, the global Intra-Dialytic Hypotension market is segmented into Hospital devices such as Hemodialysis testing devices and blood pressure monitors and Continuous hematocrit monitoring devices POC testing devices such as Continuous non-invasive arterial pressure monitor (CNAP devices) and Telemedicine.
Point-of-care (POC) devices are beneficial for patients as they monitor inter-and intra-dialytic hypotension episodes.
Based on the location of testing, the global Intra-Dialytic Hypotension market is segmented into Hospitals, Clinics and Homecare.
North America and Europe dominate the global market. Some of the key factors that are expected to be responsible for their dominance in this market are the high number of patients undergoing renal hemodialysis and a large geriatric population in these regions.
Most of the companies involved in the research and development activities in this field and have a few drugs in the pipeline also belong to these regions. Thus, it is expected that these regions will largely dominate this market in the future. However, the Asia Pacific constitutes some of the world's fastest emerging economies. An increasing number of patients with renal diseases will help grow this market in this region in the future.
Some of the major manufacturers in the Intra-Dialytic Hypotension market are Aetna, lighTouch Medical, Cnsystems Medizintechnik, Memscap, Fresenius Medical Care, SunTech Medical, W. A. Baum, Siemens Corporate Research and Omron healthcare.
For instance, Omron Healthcare Inc. has launched the 3 Series and 7 Series Wrist Blood Pressure Monitor for advanced blood pressure measurements.
The Global Intra-Dialytic Hypotension Market report would provide access to an approx. 53 market data table, 41 figures and 286 pages.
Target Audience
$4350
$4350
$4350
$4350
$4350
$4350